Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia
Adolfo A, Ferrando A, Thomas L, et al. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000;37:381-395.
Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: Experience from India
Amare P, Gladstone B, Varghese C, et al. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: Experience from India. Cancer Genet Cytogenet 1999;110:44-46.
Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals
Minenori EI, Mariko E, Eiichi I, et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001;97:737-743.
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
McLean TW, Ringold S, Neuberg D, et al. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996; 88: 4252-4258.
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A pediatric oncology group study
Harris MB, Shuster JJ, Carroll A, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a pediatric oncology group study. Blood 1992;79:3316-3324.
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and Highhyperdiploidy (>50 chromosomes)
Heerema NA, Sather HN, Sensel MG, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and Highhyperdiploidy (>50 chromosomes). J Clin Oncol 2000; 18:1876-1887.
Prognositic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
Look AT, Roberson PK, Williams DL, et al. Prognositic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985;65:1079-1086.
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Onceology Group study
Trueworthy R, Shuster J, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Onceology Group study. J Clin Oncol 1992;10: 606-613.
Six-year follow-up the clinical significance of karyotype in acute lymphoblastic leukemia
Bloomfield CD, Secker-Walker LM, Goldman SI, et al. Six-year follow-up the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989;40: 171-185.
Translocation (9; 22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia
Fletcher JA, Lynch EA, Kimball VM, et al. Translocation (9; 22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991;77:435-439.
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: Impact of the 11 q23 breakpoint on outcome: A report of the Childrens Cancer Group
Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11 q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 1994;83:2274-2284.